Clinical trial
Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica
NCT04062006 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica
- Lead sponsor
- Peking University People's Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2019
- Completion date
- June 30, 2021
- Enrollment
- 15 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.